Cannabis Investment Report – Market Overview and Strategic Investor Activity (Dec 2017)
Summary
The passage provides a generic industry analysis and mentions corporate investments by publicly traded firms, but lacks specific allegations, financial flow details, or connections to high‑level polit Constellation Brands invested ~US$190 M in Canopy Growth. Scotts Miracle‑Gro spent >US$400 M acquiring cannabis‑related supply firms. 300+ cannabis‑related companies trade globally, many on OTC marke
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Ackrell Capital Report Highlights Funding Gap and Investor Activity in Cannabis Industry
The passage provides market analysis and investment trends in the cannabis sector but lacks specific allegations, names of high‑profile officials, or actionable misconduct leads. It mentions corporate Cannabis companies raised over $2 billion in 2017, mostly from retail and family‑office investors. Strategic investors such as Constellation Brands and Scotts Miracle‑Gro have made notable investment
Cannabis Investment Report – Market Overview and Funding Landscape (Dec 2017)
The document is a generic industry analysis with no mention of high‑profile political figures, intelligence agencies, or controversial financial flows. It provides market commentary and fundraising to Reports $2.0 billion raised by cannabis‑related companies in 2017. Highlights Canadian exchanges (TSX, TSXV, CSE) as primary venues for cannabis listings. Notes ongoing U.S. federal prohibition limit
Industry overview of cannabis and hemp companies with revenue and partnership details
The passage provides commercial financial metrics and partnership information for several cannabis‑related firms. It contains no references to high‑ranking officials, government agencies, or illicit a GTI reports $41.7 M revenue with >300% YoY growth. Khiron Life Sciences entered a 50/50 JV with U.S. Dixie Brands for Latin American CBD cosmetics. Level Brands acquired CBD consumer brand cbdMD, gen
Cannabis Investment Report – December 2017 Overview of Distribution and Regulatory Landscape
The passage is a generic industry analysis without specific names, transactions, dates, or concrete allegations involving high‑profile officials or entities. It offers only broad context about tax and Highlights tax compliance risks for cannabis distributors across U.S. states. Notes potential market saturation and licensing moratoriums in Colorado. Mentions California’s new cannabis regulatory ag
Cowen report highlights strong EBITDA margins and growth forecasts for CBD companies Charlotte’s Web and CV Sciences
The passage provides financial performance data and growth projections for publicly traded cannabis firms, but it does not link any high‑ranking officials, government agencies, or controversial action Charlotte’s Web and CV Sciences report EBITDA margins above 30% in the most recent quarter. Charlotte’s Web projected 2018 revenue of $65‑80 million and 2019 revenue of $120‑170 million. Analysts exp
Cannabis Investment Report shows stock gains tied to political announcements
The passage merely reports market performance linked to publicly known political events (Trudeau's legalization plan, Trump election, Sessions appointment) and a corporate investment. It offers no con Canadian cannabis stocks rose after Prime Minister Justin Trudeau announced recreational legalizatio U.S. cannabis stocks remained resilient despite Donald Trump's election and Jeff Sessions as Attor
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.